Fexofenadine |
Allegra |
Fexofenadine Systematic (IUPAC) name 2-[4-[1-hydroxy-4-[4-(hydroxy-diphenyl- methyl)-1-piperidyl]butyl]phenyl]-2- methyl-propanoic acid Identifiers CAS number 83799-24-0 ATC code R06A626 PubChem 3348 DrugBank APRD00349 Chemical data Formula C32H39NO4 Mol. weight 501.656 Pharmacokinetic data Bioavailability Not yet established Protein binding 60-70% Metabolism Hepatic (5% of dose) Half life 14.4 hours Excretion Biliary , fecal and renal Therapeutic co ...
Wikipedia - [full article]
Fexofenadine Clinical Trials
- Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
ClinicalTrials.gov Identifier: NCT00435461 - Active, not recruiting
Hayfever; Allergic Rhinitis
- Long-term Safety Performance of Fexofenadine in Asthma
ClinicalTrials.gov Identifier: NCT00045955 - Completed
Asthma
- Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
ClinicalTrials.gov Identifier: NCT00044811 - Completed
Asthma
- Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
ClinicalTrials.gov Identifier: NCT00044824 - Completed
Asthma
- Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
ClinicalTrials.gov Identifier: NCT00502775 - Recruiting
Allergic Rhinitis; Hay Fever
- Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken with Lopinavir/Ritonavir in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00103012 - Recruiting
- Fexofenadine in Pruritic Skin Disease
ClinicalTrials.gov Identifier: NCT00261079 - Completed
Pruritus
- Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model.
ClinicalTrials.gov Identifier: NCT00547768 - Completed
Allergy
- Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis
ClinicalTrials.gov Identifier: NCT00542607 - Completed
Rhinitis, Allergic, Seasonal
Resources
- Allegra (Drug Digest)
- Fexofenadine (Drug Digest)

Not Signed In -

